CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...